Alvarado García A, Gaviño Ambriz S
Ginecol Obstet Mex. 1998 Apr;66:173-8.
Evaluation of oral treatment in vaginitis and vaginosis using Itraconazol and sechidazol, in comparison to topic treatment using vaginal ovules of acetonido of fluocinolona 0.50 mg, nistatina 100,000 U and metronidazol 500 mg.
Longitudinal, prospective and open comparative study.
Servicio de Reproducción Humana(Human Reproduction Department), Centro Médico Nacional "20 de Noviembre".
Forty female patients, without any relevant differences in their general characteristics, chose diagnosis was vaginitis and vaginosis, who were medically treated through external consultation, divided in two groups of twenty each one. Group 1 oral treatment with itraconazol and secnidazol. Group 2 had topic treatment with fluocinolona, nistatina and metronidazol. All of the patients were controlled in seven and fourteen days time, in order to evaluate the intensity of their clinical symptomatology, as well as the efficacy in both ways of treatment.
Leukorrhea was the most important symptom in all the cases, going from minor to serious white discharge. After the treatment, we found a relevant difference statistically significative in patients treated with intraconazol and secnidazol. We did not find any differences in relation to ardor, pruritus, dispareunia and disuria at post-treatment evaluation. However, group 1 betterment was statistically significative between the first and the seventh days of treatment.
Treating vaginitis or vaginosis (or both) with itraconazol and secnidazol takes less time for betterment in addition to comfort and easiness of oral administration; therefore, we consider them proper medicines in these specific cases.
评估伊曲康唑和塞康唑口服治疗阴道炎和阴道病的效果,并与使用含0.50毫克氟轻松醋酸酯、100,000单位制霉菌素和500毫克甲硝唑的阴道栓剂进行局部治疗的效果作比较。
纵向、前瞻性和开放性对比研究。
国家医学中心“11月20日”人类生殖科。
40名女性患者,其一般特征无任何相关差异,诊断为阴道炎和阴道病,通过门诊接受药物治疗,分为两组,每组20人。第1组采用伊曲康唑和塞康唑口服治疗。第2组采用氟轻松、制霉菌素和甲硝唑进行局部治疗。所有患者在7天和14天时接受检查,以评估其临床症状的严重程度以及两种治疗方法的疗效。
白带异常是所有病例中最重要的症状,从轻微到严重的白带增多。治疗后,我们发现使用伊曲康唑和塞康唑治疗的患者在统计学上有显著差异。在治疗后评估中,我们未发现与灼热感、瘙痒、性交困难和排尿困难有关的差异。然而,第1组在治疗的第1天和第7天之间的改善在统计学上具有显著意义。
使用伊曲康唑和塞康唑治疗阴道炎或阴道病(或两者)除了口服给药舒适方便外,改善症状所需时间更短;因此,我们认为它们是这些特定病例的合适药物。